Product Description
| Cat Number | CV-050 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Binds to the SARS-CoV-2 receptor binding domain |
| Modification | C terminal amide |
| Purity | >95% by HPLC |
| Biomarker Target | Protein-protein interactions,Angiotensin converting enzyme,Antivirals |
| Sequence Three Letter Code | H-Ile-Glu-Glu-Gln-Ala-Lys-Thr-Phe-Leu-Asp-Lys-Phe-Asn-His-Glu-Ala-Glu-Asp-Leu-Phe-Tyr-Gln-Ser-NH2 |
| Molecular Formula | C127H185N31O41 |
| Sl Sequence | IEEQAKTFLDKFNHEAEDLFYQS-NH2 |
| Solubility | Soluble to 1 mg/ml in water |
| Appearance | Freeze dried solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Zhang et al (2020) The first-in-class peptide binder to the SARS-CoV-2 spike protein. bioRxiv 2020.03.19.999318; doi: https://doi.org/10.1101/2020.03.19.999318Zhang et al (2020) Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD. bioRxiv 2020.03.19.999318; doi: https://doi.org/10.1101/2020.03.19.999318 Related areasAll peptides >All angiotensin converting enzyme modulators >All antivirals > |
| Note | The product is for research use only |
Share Item: